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Using affinity purificationMS approaches, we have identified
a novel role for casein kinase II (CKII) in themodification of the
polymerase associated factor complex (PAF-C). Our data indi-
cate that the facilitates chromatin transcription complex
(FACT) interacts with CKII and may facilitate PAF complex
phosphorylation. Posttranslational modification analysis of af-
finity-isolated PAF-C shows extensive CKII phosphorylation of
all five subunits of PAF-C, although CKII subunits were not
detected as interacting partners. Consistent with this, recombi-
nantCKIIorFACT-associatedCKII isolated fromcellscanphos-
phorylate PAF-C in vitro, whereas no intrinsic kinase activity
was detected in PAF-C samples. Significantly, PAF-C purifica-
tions combined with stable isotope labeling in cells (SILAC)
quantitation for PAF-C phosphorylation from wild-type and
CKII temperature-sensitive strains (cka1 cka2–8) showed that
PAF-C phosphorylation at consensus CKII sites is significantly
reduced in cka1 cka2–8 strains. Consistent with a role of CKII
in FACT and PAF-C function, we show that decreased CKII
function in vivo results in decreased levels of histoneH2B lysine
123 monoubiquitylation, a modification dependent on FACT
and PAF-C. Taken together, our results define a coordinated
role of CKII and FACT in the regulation of RNApolymerase II
transcription through chromatin via phosphorylation of
PAF-C.
Transcription elongation byRNApolymerase II (RNAPII)4 is
a coordinated process that is regulated to ensure the proper
expression of protein-coding genes. Numerous protein com-
plexes play a role in aiding RNAPII loading onto a target gene
promoter through the formation of preinitiation complexes.
Following initiation, RNAPII proceeds into productive tran-
script elongation, during which the enzyme must cope with a
chromatin landscape that can have an inhibitory effect on
RNAPII passage. The polymerase-associated factor complex
(PAF-C) plays a central role in the regulation of RNAPII elon-
gation and co-transcriptional histone methylation at histone
H3 lysine residues 4 and 36 as well as monoubiquitylation of
histone H2B at lysine 123 (H2B-K123ub1, (1–5)). In the model
organism Saccharomyces cerevisiae, PAF-C is composed of five
subunits: Cdc73, Ctr9, Leo1, Paf1, andRtf1 (6). The humanPaf1
complex contains an additional subunit, Ski8, which has been
shown to be important in 3-5mRNA degradation (7). Human
PAF-C has been shown to interact directly with RNAPII (8).
Various studies in yeast have linked PAF-C function to the
facilitates chromatin transcription (FACT) complex, a histone
chaperone that facilitates removal of a H2A/H2B dimer during
transcription and replacement of that dimer following RNAPII
passage (9–11). The FACT complex is composed of Spt16 and
Pob3. FACTmakes contacts with the H2A/H2B dimer and has
also been shown to interact with histones H3/H4, histone tails,
and intact nucleosomes in some contexts (10, 12–15). Spt16
associates with all five subunits of yeast PAF-C as well as casein
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kinase II (CKII), as determined by qualitative mass spectrome-
try analysis (16). Affinity purification experiments have shown
that PAF-C interacts genetically and physically with conserved
transcription elongation factors, including Spt6, 5,6-dichloro-
1--D-ribofuranosylbenzimidazole sensitivity-inducing factor,
and FACT (16, 17). It has been proposed that Paf1mediates the
interaction between FACT and RNAPII in yeast (18). In higher
eukaryotes, human PAF-C has been shown to interact with the
general transcription elongation factor Transcription factor
SII, the superelongation complex, and the FACT complex, con-
sistent with its known interactions in yeast (8).
CKII is an abundant and constitutively active serine kinase
that phosphorylatesmany targets in yeast andmammalian cells
(19, 20). CKII contributes to the pathology of many human
cancers (21–23). Multiple complexes containing CKII have
been identified, including the transcription elongation factor
FACT (16, 24). In mammalian cells, FACT co-purifies with
CKII in a complex that phosphorylates p53 on serine 392 in
response to DNA damage (24). In addition, deletionmutants of
CKII exhibit defective transcription of specific cell-cycle genes,
which results in a delay in entrance into S phase (25).
Quantitative analysis of dynamic protein interactions re-
mains a significant challenge for proteomics because transient
interaction partners are obtained at substoichiometric levels
relative to bait proteins (reviewed in Ref. 26). Here we focused
on the transient interactome of FACT and PAF-C and found
that they are interaction partners with CKII. The use of hierar-
chical clustering and normalized spectra abundance factor
(NSAF) values from multiple baits readily identify reciprocal
interactions between FACT/CKII and PAF-C/RNAPII. In-
depth mass spectrometry analysis using MudPIT of biological
replicate purifications of the FACT complex (Spt16-TAP) iso-
lated under low-salt conditions followed by significance analy-
sis of interactome (SAINT) resulted in the identification of sta-
tistically significant interactions between FACT, CKII, PAF-C,
and histones. Additionally, we show that all five subunits of
PAF-C are targeted for phosphorylation by CKII in vivo.
Although PAF-C is subjected to extensive phosphorylation by
CKII, reciprocal interactions between CKII and PAF-C were
not observed. However, reciprocal interactions were detected
between CKII and FACT, suggesting that the FACT complex
may facilitate CKII modification of PAF-C. In support of this
idea,weshowthatCKIIcopurifiedwithSpt16-TAPreadilyphos-
phorylates PAF-C in vitro, whereas no detectable kinase activity
copurified with PAF-C through Ctr9-FLAG. In addition, we
purified PAF-C from WT and CKII-defective cells using a
SILAC approach and definitively show that CKII activity is
required for phosphorylation of multiple residues across the
subunits of PAF-C. Finally, and consistent with a role for CKII
in PAF-C and FACT function, we show that temperature-sen-
sitive mutants of CKII display reduced levels of histone
H2B-K123ub1.
Experimental Procedures
Yeast Strains and Growth Conditions—All yeast strains are
listed in supplemental Table S1. Gene deletions were per-
formed using gene replacement (27). All expression plasmids
contained the endogenous gene promoter.Mutagenesis of plas-
mids was performed with the QuikChange Lightning Multi
site-directed mutagenesis kit (Agilent Technologies) with the
primers and plasmids described in supplemental Table S2. Plas-
mids were transformed into deletion strains using standard
methods (28). Endogenous Paf1 and Ctr9 were C-terminally
tagged with the 3-FLAG epitope using the p3FLAG plasmid
(29). All strains were confirmed by Western blotting and PCR.
TAP-tagged cells used for standard purifications were grown to
an A600  2.0–2.5 in yeast extract, peptone, dextrose medium
and pelleted by centrifugation. For stable isotope labeling in
cells (SILAC) experiments, precultures of Ctr9-FLAGWT and
cka1 cka2–8 were grown in yeast nitrogen base 2% glucose
without arginine or lysine overnight. The cka2–8 allele is a
temperature-sensitive mutant with defective function at 25 °C
and 37 °C (30–32). The precultures were used to inoculate
3-literculturesofCtr9-FLAGWTcells inyeastnitrogenbase2%glu-
cose containing [13C6,15N2]lysine and [13C6,15N4]arginine,
referred to as heavy medium. The Ctr9-FLAG mutant cka1
cka2–8 was grown in YNB 2% glucose containing standard
12C,14N-containing lysine and arginine, referred to as light
medium. For the SILAC experiment, cells were grown to an
A600 1.5–2.0 at 30 °C and then subjected to a 2-h heat shock
at 37 °C.
Affinity Purifications—Tandem affinity purifications (TAPs)
were performed as essentially described by Puig et al. (33) and
Mosley et al. (34–36). Control purifications were performed
from untagged parental strains (BY4741 for the TAP strains).
Cell pellets were resuspended in lysis buffer (40 mM Hepes-
KOH (pH 7.5), 10% glycerol, 100 or 350 mM NaCl (depending
upon purification), 0.1% Tween 20, 0.5 mM DTT, 2 mM Na
orthovanadate, and fresh yeast protease inhibitor mixture) and
lysed using glass beads in a bead beater. The resulting lysate was
treated with DNaseI and heparin sulfate at room temperature
for 10min to release any chromatin-bound proteins. The lysate
was cleared by centrifugation and incubatedwith 500l of IgG-
Sepharose (GE Healthcare) beads overnight at 4 °C. The slurry
was washed to remove nonspecific binding proteins, resus-
pended in tobacco etch virus (TEV) protease cleavage buffer,
and incubated with 100 units of AcTEVTM (Invitrogen) prote-
ase overnight at 4 °C. A disposable Poly-prep chromatography
columnwas used to separate the beads from the cleaved protein
by gravity flow. The beads, retained on the column, were
washed with Calmodulin binding buffer. The protein flow-
through was incubated with Calmodulin-Sepharose beads for
3 h at 4 °C and eluted from the beads with Calmodulin elution
buffer containing 2 mM EGTA. FLAG tag affinity purifications
were performed as described above with the following changes.
After clarification of the lysate by centrifugation, the lysate was
incubated with 500 l of anti-FLAG M2 affinity resin (Sigma)
overnight at 4 °C. The next day, the lysate/resin slurry was
passed through a disposable Poly-prep chromatography col-
umn to capture the FLAG resin. The resin was then washed
extensively with lysis buffer prior to 3 FLAG peptide elution.
The elutions were performed by incubation of the resin with
250 l of a 1 mg/ml solution of 3 FLAG peptide resuspended
in lysis buffer. Following elution, the resin was washed with an
additional 250 l of lysis buffer that was also collected with the
eluate. This process was repeated three to four times. Affinity
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purification elutions were TCA-precipitated overnight at 4 °C,
followed by overnight digestionwith endoproteinase Lys-C and
then another overnight digestion with Trypsin Gold (Promega)
at 37 °C. All digestions were quenched with formic acid to a
final concentration of5%.
MudPIT Mass Spectrometry and Database Searching—Pep-
tide mixtures were analyzed by MudPIT mass spectrometry as
described previously (37). Each sample was pressure-loaded
onto a 100-m fused-silica nanospray column pulled to an
5-m tip using a P-2000 laser puller. The microcapillary col-
umns contained two C18 reverse phases (Aqua, Phenomenex)
separated by strong cation exchange resin (Luna, Phenome-
nex). Each MudPIT column was placed in line with the LTQ
Velos ion trap or LTQVelosOrbitrapmass spectrometer, and a
spray voltage of 2.0 kV was applied to the nanocolumn. The
automated MudPIT cycles consisted of four to ten 120-min
steps with increasing concentrations of ammonium acetate.
Four-step MudPIT consisted of 8-l injections of 50, 100, 200,
and 300 mM ammonium acetate, respectively, followed by a
20-min wash with buffer A (5% acetonitrile and 0.1% formic
acid) and then a 90-min organic gradient of 5–80% buffer B
(80% acetonitrile and 0.1% formic acid) to facilitate peptide elu-
tion from the reverse-phase resin. Four MudPIT steps were
used for the SILAC-labeled Ctr9-FLAG purifications. Ten-step
MudPIT consisted of 8-l injections of 25, 50, 75, 100, 150, 200,
250, 300, and two350mMammoniumacetate steps, followedby
a buffer A wash and buffer B gradient as described above. Ten-
stepMudPITwas performed for all otherAP-MS samples. Each
full scan (at a resolution of 60,000 in theOrbitrap) was followed
by 10–15 MS/MS scans using data-dependent acquisition in
the ion trap, where the most intense precursor ions were indi-
vidually fragmented by collision-induced dissociation (collision
energy 35).
Database searching of the RAW files was first done with
SEQUEST HT (version 1.4.1.14) in Proteome Discoverer
(1.4.0.288) using trypsin as the enzyme restriction and the fol-
lowing parameters: two missed cleavages for trypsin, a precur-
sor mass tolerance of 1.4 Da for ion trap data and 10 ppm for
Orbitrap data, a fragmentmass tolerance of 1.0 daltons, aCN
value of [mteq]0.15, and a fixed modification of 57 Da on
cysteine residues and variable modifications of 16 Da on
methionine and80 daltons on serine, tyrosine, and threonine.
The SILAC experiments were searched as above but included
dynamicmodifications for [13C6,15N2]lysine and [13C6,15N4]ar-
ginine. A custom S. cerevisiae FASTA database was used for a
database search that contained 6631 protein sequences, includ-
ing the entire yeast proteome from Uniprot (downloaded on
February 27, 2014), and150 common contaminant proteins,
including proteolytic enzymes, human keratins, and common
laboratory contaminants. Additionally, we included the peptide
sequence for the TAP tag used for isolation of all protein com-
plexes studied. The PSM counts for the TAP tag weremanually
added to the PSMcount of the bait (i.e.TAP-tagged) subunit for
subsequent quantitative analysis. The msf files from Proteome
Discoverer were imported into Scaffold 4, and the peptides
from Scaffold were used for subsequent quantitative and post-
translational modification analysis for SAINT. The data
obtained for the SILAC experiments were analyzed by the
quantitationmodulewithin ProteomeDiscoverer 1.4 (Thermo)
to calculate the total peak area for each precursor ion and the
relative ratio of heavy to light precursor ions. For posttransla-
tional modification analysis of Cdc73-TAP, spectra were ana-
lyzed with X!Tandem with the addition of protein N-terminal
acetylation (42 Da) as a dynamic search option. Each protein
is required to have at least two peptides to be considered iden-
tified. Additionally, site-specific modifications are reported
frommanual interpretation of spectra to confirm the fragment
ion coverage of the specific phosphorylation site. Peptides used
for phosphorylation mapping were also required to have150
ppm from the LTQ Velos ion trap or 10 ppm from the LTQ
Velos Orbitrap. Peptide spectrum matches (PSMs) used for
protein interaction analysis were identified at a peptide false
discovery rate of less than or equal to 1% as calculated by Scaf-
fold. Hierarchical clustering analysis was performed as
described previously (35, 36). The peptide and protein identifi-
cations for the Spt16-TAP (n  4), and Cdc73-TAP (n  3)
purifications are available upon request. Additionally all RAW
data files, Scaffold data files, and peak list files have been depos-
ited into the MassIVE data repository under the title “FACT,
PAF-C, and CKII.”
Label-free Quantitative Proteomics Approaches for Interac-
tome Analysis—The total number of PSMs passing the criteria
listed above were used for relative quantitation using the fol-
lowing approaches. Two empirical –fold change scores were
calculated (38). The first, referred to as FC-A, calculates the
-fold enrichment of affinity purifications over control purifica-
tions using the average mean of the PSMs per protein across
replicates. The second score, referred to as FC-B, calculates the
-fold change over control using the geometric mean of repli-
cates. SAINT probability scores were also calculated for Spt16-
TAP replicates as described previously using the Contaminant
Repository for Affinity Purification (CRAPome) web site as
detailed in multiple publications (37–42). Finally, we also nor-
malized the total spectral abundance for proteins of interest
usingNSAF calculations as described previously (35, 36, 43, 44).
In Vitro Kinase Assays—For kinase reactions, 300 ng of
low-salt (100 mM) purified Spt16-TAP-associated proteins
and/or Ctr9-FLAG-associated proteins were incubated alone,
in combination, or with recombinant CKII (Millipore) for 2 h at
30 °C in kinase buffer (40 mMHEPES (pH 7.5), 10 mMMgCl2, 5
mM dithiothreitol, and 10 Ci of [-32P]ATP (6000 Ci/mmol,
PerkinElmer Life Sciences)). Kinase reactions were stopped by
the addition of 2 SDS-PAGE loading buffer and boiling at
100 °C for 10min. Reactionswere then separated by SDS-PAGE
on a 10–20% precast gel (Bio-Rad). The gels were dried under a
vacuumprior to exposure to a PhosphorImager screen for1 h
prior to scanning on a Fuji scanner.
Immunoblotting—Yeast cells of the indicated genotypes
along with their wild-type counterparts were grown in YPD
either at permissive or restrictive temperatures. Overnight-sat-
urated cultures were back-diluted to an A600 of 0.2 and allowed
to grow until they reached anA600 of 1. FiveA600 equivalents of
cells were lysed by bead beating using SUMEB lysis buffer con-
taining 1% SDS, 8 M urea, 10mMMOPS (pH 6.8), 10mMEDTA,
and 0.01% bromphenol blue). Lysates were separated by SDS-
PAGE and probed using anti-HA (UNCAntibodyCore Facility,
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clone 12CA5, 1:5000), anti-glyceraldehyde 6-phosphate dehy-
drogenase (G6PDH) (Sigma-Aldrich, A9521, 1:100,000), anti-
histone H2B-K123ub1 (Cell Signaling Technology, 5546S,
1:1000), anti-histone H2B (Active Motif, 39237, 1:50,000), and
anti-histone H3 lysine 4 trimethylation (EpiCypher, 13-0004,
1:5000). HRP-conjugated anti-rabbit or anti-mouse secondary
(1:10,000) antibody was used, and the signal was detected using
ECL Prime or ECL (Amersham Biosciences).
Results
During the transcription cycle, RNAPII interacts with
numerous accessory proteins to facilitate transcription initia-
tion, elongation through chromatin, co-transcriptional RNA
processing and transcription termination. Unlike RNA poly-
merase I and III, which have “built-in” elongation factor activ-
ities, all RNAPII-associated elongation factors interact in a
dynamic fashion (35, 45). One approach to study transient
interaction partners usingAP-MS is to perform reciprocal puri-
fication of low-level prey proteins to confirm the interaction
with the original bait protein of interest (Fig. 1). Although this
approach is common, the coordinated analysis of these purifi-
cations using quantitative approaches is not often performed in
favor of more standard qualitative (presence or absence) anal-
ysis. In this study, we chose to perform four biological replicate
purifications of Spt16-TAP under low-salt (LS, 100 mM NaCl)
conditions to facilitate the capture of transient interacting pro-
teins because FACT was the lowest-level RNAPII interaction
partner known from previous studies identified in Rpb3-TAP
purifications (35, 36). A representative Spt16-TAP LS purifica-
tion was used for hierarchical clustering analysis (Fig. 1, A, left
panel, andB, second column). A high-salt (350mMNaCl) purifica-
tion was also performed for Spt16-TAP for comparison (Fig. 1B,
first column). In addition, we performed MudPIT analysis of
Ckb2-TAP (a subunit of casein kinase II) and Cdc73-TAP (a sub-
unit of PAF-C) and included datasets published previously for
Spt4-TAP, Tfg1-TAP (a subunit of TFIIF), and Rpb11-TAP for
comparison (36) (Fig. 1). For each dataset, NSAF values were cal-
culated and analyzed by hierarchical clustering.
As shown in Fig. 1B, hierarchical clustering readily separates
the known protein complexes into groups based on the AP-MS
data (see dendrogram on the left and compare with protein
complex labels on the right). Using these data, the Spt4/Spt5
heterodimer is readily identified as a complex based on the high
abundance of the complex in Spt4-TAP samples. Overall, the
cluster analysis identified two main sets of elongation factors.
The first set includes TFIIF, Spt4/Spt5, and PAF-C as interac-
tion partners that readily co-purify with RNAPII (Fig. 1B, bot-
tom 3⁄4 of the cluster). The second set includes FACT and CKII,
which appear to interact with PAF-C under low-salt conditions
when using Spt16-TAP as bait (Fig. 1B, top 1⁄4 of the cluster).
These data support two previously reportedmodels: FACT can
act as a complex with CKII (24), and PAF-C can serve as a
scaffold to recruit FACT to RNAPII (18).
SAINT calculates interaction probabilities for proteins that
are isolated through affinity purification approaches (referred
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to as prey), such as TAP and FLAG purifications. In our analy-
sis, the specific bait purifications (Spt16-TAPLS) are compared
with mock purifications from untagged parental strains. Using
SAINT, we analyzed the four Spt16-TAP LS biological repli-
cates to identify significant interaction partners of FACT
(supplemental Table S3). In addition to the FACT complex
itself, histones H2A, H2B, and H4 (Htb1, Htb2, and Hht1,
respectively), all four subunits of CKII, and the five subunits of
PAF-C had SAINT scores of0.75 (Fig. 2). Additional signifi-
cant interaction partners of Spt16 are listed in supplemental
Table S3. There are also low-level PSM values identified in rep-
licate Spt16-TAP samples for the two largest subunits of RNA-
PII (Rpb1 and Rpb2), but these interactions were not signifi-
cantly enriched over controls. The interaction values from this
purification span 4 orders of magnitude, perhaps revealing the
true dynamic nature of protein interactions with the FACT
complex.
The data presented so far clearly suggest a reproducible yet
dynamic relationship between FACT, CKII, and PAF-C. The
data obtained from Spt16-TAP low-salt purifications provide
convincing evidence for protein interactions between FACT,
CKII, and PAF-C. However, reciprocal purifications of PAF-C
did not result in high levels of co-purifying FACT or CKII (Fig.
1).We next chose to further characterize the potential dynamic
protein interaction between PAF-C and CKII in more detail.
CKII is a constitutively active serine/threonine kinase that has
been implicated in the phosphorylation of a number of tran-
scription-related proteins including RNAPII itself (46). Multi-
ple consensus motifs have been defined that are phosphory-
lated by CKII, including [S/T]XX[E/D] (47), SDXE, SXX[E/D],
and [D/E]S[D/E]X[D/E] andmany other similarmotifs (48, 49).
Kinase-substrate interactions have also been characterized as
highly transient, and previous studies using AP-MS to charac-
terize these interactions have used approaches, including
kinase overexpression, to increase the overall chance of catch-
ing a snapshot of these quick reactions (41). To determine
whether PAF-C and/or FACT subunits are substrates of CKII,
we performed dynamic posttranslationalmodification searches
for serine, threonine, or tyrosine phosphorylation on Spt16-
TAP and Cdc73-TAP purifications. Using this approach, we
found that all five subunits of PAF-C are putative CKII targets,
suggesting that PAF-C and CKII are not only direct interacting
partners but that the interaction rates are likely too rapid to
capture high levels of CKII subunits in PAF-C purifications
(supplemental Table S4, Fig. 3). Two of the phosphorylation
sites, Ser422 in Paf1 and Ser358 in Leo1, consist of a SPD/E
sequence, which suggests that these sites could be targets of
cyclin-dependent kinases or CKII based on their consensus
motifs (49). Three of the PAF-C subunits (Ctr9, Paf1, and Rtf1)
are putatively modified by CKII at multiple sites (Figs. 3, A, C,
and D, with representative phosphosite mapping spectra pro-
vided in supplemental Fig. S1). Serine 132 in Leo1, a putative
CKII consensus site, is modified in over 80% of the PSMs iden-
tified that contain that amino acid.
To define the consensus motifs for the PAF-C amino acids
modified by CKII, we performed sequence enrichment analysis
using Seq2Logo (50) (Fig. 4B). The major consensus sequence
(n 10 sites) for PAF-C phosphorylation sites is SDX[D/E][D/
E]XD, which strongly resembles previously defined CKII phos-
phorylation motifs (48, 49) (Fig. 3 and supplemental Table S4).
These data, in light of our protein interaction analysis, suggest
that FACT may facilitate CKII recruitment to PAF-C for its
subsequent phosphorylation (18). Although we performed full
phosphorylation analyses of the FACT subunits Spt16 and
Pob3, we did not identify any phosphorylated peptides in either
protein. However, the C-terminal domain sequence of Spt16
was not detected in our analyses, suggesting that alternate pro-
tease digestions may be needed to fully analyze potential mod-
ification sites in FACT.
We next performed a series of experiments to confirm that
the subunits of PAF-C are bona fide substrates of CKII using
both in vitro and in vivo approaches. Using [32P]ATP, we first
performed in vitro kinase assays using LS Spt16-TAP-purified
FACT and Ctr9-FLAG-purified PAF-C as substrates in the
presence or absence or recombinant CKII. As shown in Fig. 4A,
lane 2, proteins corresponding to the molecular weight of both
subunits of the FACT complex can be phosphorylated in vitro
in reactions containing recombinant CKII (Fig. 4A, Spt16 and
Pob3). Recombinant CKII is also autophosphorylated in this
experiment, as visualized in Fig. 4A, lane 5, which only contains
recombinant CKII and ATP. Interestingly, phosphorylated
Spt16 and Pob3 bands were also visualized in reactions lacking
recombinant CKII, suggesting that CKII (or potentially some
other co-purifying kinase) can also phosphorylate FACT in
vitro (Fig. 4A). Importantly, we found that PAF-Cwas not phos-
phorylated in the absence of recombinant CKII, suggesting that
CKII is not a stable interacting partner of PAF-C (Fig. 4A, lane
3). These data are also in agreement with our AP-MS studies
(Figs. 1 and 2). In contrast, four bands corresponding to the
molecular weights of PAF-C subunits are readily phosphory-
lated in the presence of recombinant CKII (Fig. 4A, lane 4).
Notably, we did find that four of the five PAF-C subunits were
phosphorylated in our in vitro reaction following incubation
with Spt16-TAP and ATP (Fig. 4B, lane 3). These data clearly
show that the FACT-CKII complex will readily phosphorylate
PAF-C in vitro.
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To test whether CKII is responsible for phosphorylation of
PAF-C using an in vivo approach, we performed quantitative
proteomics analysis of Ctr9-FLAG-isolated PAF-C complexes
from WT and CKII temperature-sensitive strains (cka1
cka2–8) using SILAC-based quantitation (Fig. 5). The experi-
mental scheme used for these studies is shown in Fig. 5A. Both
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WT and CKII temperature-sensitive strains were grown to an
A600 1.5 and thenheat shocked at 37 °C for 2 hprior tomixing
of the cell pellets, lysis, and PAF-C purification. The full set of
significantly changed peptides identified in the Ctr9-FLAG
SILAC dataset is included in supplemental Table S5. As shown
in supplemental Table S5, we readily identified peptides for 10
phosphorylation sites across four subunits of PAF-C for which
the levels of the phosphorylated peptides decreased, whereas
the unmodified peptides increased in cka1 cka2–8 (light) ver-
sus the WT (heavy). Although we observed multiple decreases
in the level of phosphopeptides in cka1 cka2–8, the relative
protein abundance of all five PAF-C subunits was unchanged
(Fig. 5B). TheMS1precursor intensity for the isotopic peaks are
shown for representative Leo1 peptides KFYGEDANNFSDQ-
DETTHTFKEENVELVR and KFYGEDANNFSPO4DQDETT-
HTFKEENV-ELVR containing unmodified or phosphorylated
serine 132, respectively (Fig. 5, C andD). TheMS1 intensity for
peptide ions containing unmodified Leo1 serine 132 increased
2.5-fold following heat shock of cka1 cka2–8 strains (Fig. 5C).
The opposite trend was observed for Leo1 serine 132, with a
3-fold decrease in the abundance ofMS1 area (Fig. 5D). Similar
trends were observed for the other putative CKII sites in Ctr9,
Paf1, and Rtf1, suggesting that these are CKII targets (supple-
mental Table S5). Overall, these data convincingly show that
PAF-C is a bona fide substrate of CKII in vivo. Interestingly, we
also observed increased threonine 127 phosphorylation in Paf1.
These data suggest that other kinasesmay partially compensate
for the loss of CKII activity following heat shock of cka1
cka2–8 strains to regulate Paf1 phosphorylation (supplemental
Table S5).
We next assessed the functional consequences of CKII dis-
ruption on the biological pathways that are known to require
PAF-C and FACT. Both complexes are known to regulate post-
translational histone modifications, including H2B-K123ub1.
Histone H2B-K123ub1 occurs during RNAPII transcription
elongation and is a regulatory event for histoneH3 lysinemeth-
ylation at Lys4 and Lys79 (11, 51–55). Because CKII is responsi-
ble for extensive modification of PAF-C, we analyzed the effect
of CKII disruption on H2B-K123ub1 levels in WT, cka1
CKA2, and cka1 cka2–8 strains (Fig. 6A). At restrictive tem-
peratures of 25 °C and 37 °C, where the activity of CKII is com-
promised in cka1 cka2–8 (32), the levels of H2B-K123ub1 are
decreased in cka1 cka2–8 strains relative to the levels of total
histone H2B. Additionally, the levels of histone H2B-K123ub1
were decreased in cka1 CKA2 following incubation at the
restrictive temperatures (Fig. 6A). No changes in histone H3K4
methylation levels were observed, which is in line with studies
that show that reduced H2B-K123ub1 levels can occur without
significant effects on H3K4 methylation (56). Taken together,
these data show that CKII is an important regulator of histone
H2B-K123ub1, likely through its regulation of PAF-C and
FACT. Additional analysis of phosphosite mutants of the
PAF-C subunits Paf1, Ctr9, and Cdc73 did not individually
reveal defects in histone modification levels at H2B-K123ub1,
histoneH3lysine4trimethylation,orhistoneH3lysine36trimeth-
ylation (Fig. 6B). In addition, although strains with defective
PAF-C are sensitive to the transcription elongation inhibitor
6-azauracil or hydroxyurea (16, 17, 57–60), the phosphosite
mutants did not display growth defects when exposed to these
drugs (data not shown). These data suggest that changes in the
phosphorylation of multiple subunits of PAF-C and/or FACT
may be required to recapitulate the phenotype observed in
cka1 cka2–8.Regardless, these findings suggest that CKII acts
upstream of PAF-C and FACT as well as to regulate H2B-
K123ub1 levels. However, the precise mechanisms through
which this regulation occurs remain to be determined.
Discussion
In this study, we have performed an in-depth proteomics and
genetic analysis of two transiently associated RNAPII elonga-
tion factors that are recruited to target genes during active gene
transcription. Although PAF-C subunits were not identified as
significant interaction partners of RNAPII when using Rpb3-
TAP as bait in previous studies, purification of PAF-C through
Cdc73-TAP revealed that RNAPII is a major interaction part-
ner of PAF-C (Fig. 1). However, purifications of FACT through
Spt16-TAP under low-salt conditions revealed a significant
interaction between FACT and PAF-C (supplemental Table S3
and Fig. 2). These data suggest that PAF-C may be involved in
FACT recruitment to RNAPII, as has been hypothesized previ-
ously, because PAF-C readily interacts with RNAPII in affinity
purifications (18). FACT readily co-purifies with CKII in low-
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FIGURE 4. In vitro phosphorylation of FACT and PAF-C by CKII. A, autora-
diograph of a representative set of in vitro reactions performed with
[32P]ATP in the presence or absence of Ctr9-FLAG, Spt16-TAP, or recombi-
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salt purifications. Although Cdc73-TAP samples did not con-
tain significant levels of FACT or CKII subunit peptides, we
found that four of five subunits of PAF-C are phosphorylated by
CKII in vitro and in vivo (Figs. 3–5). In addition, we found that
Spt16-interacting CKII can readily phosphorylate purified
PAF-C in vitro (Fig. 4B). Together, these findings implicate the
FACT complex in phosphorylation of PAF-C by CKII. The
human FACT complex has been proposed previously to play a
similar role in the regulation of p53 phosphorylation by CKII
(24).
Previous studies have addressed the challenge of transient
interaction partners by overexpression of bait proteins (specif-
ically kinases) to increase the relative abundance of significant
protein-protein interactions (41). However, this approach
could result in a large number of false positive interactions as a
result of overexpression effects on the biological system in
question. Additionally, single affinity purifications have been
suggested as an approach to capture dynamic interaction part-
ners. Unfortunately, single affinity purifications also have sig-
nificantly higher interactions with cellular contaminants that,
in our experience, are not removed by algorithms such as
SAINT (37). Dynamic or transient interaction partners present
even more of a challenge to existing statistical programs than
small proteins (discussed above). This study suggests that
inclusion of a large number of replicates in combination with
follow-up reciprocal purifications and functional studies is the
most robust approach for characterization of dynamic interac-
tions such as thosewith kinases likeCKII. However, itmust also
be acknowledged that the low detection frequency of transient
interaction partners is a significant challenge for data-depen-
dent acquisition-based approaches and their related statistical
interpretation. For instance, confirmation of PAF-C modifica-
1180 1185 1190 1195m/z
0
2
4
6
8
10
864 866 868 870 872 874 876
m/z
0
1
2
3
4
5
6
A
re
a 
x 
10
6 
(c
ou
nt
s 
• s
ec
)
A
re
a 
x 
10
6 
(c
ou
nt
s 
• s
ec
)
cka1∆ cka2-8WT
1. OD600 = 1.5
2. HS @ 37°C x 2 hrs
3. Pellet cells and wash
Heavy
media
Light
media
4. Mix 1:1 based on cell number
5. FLAG purification
Leo1 S132 unmodified
cka1∆ cka2-8 Wild-type
cka1∆ cka2-8 Wild-type
Leo1 S132 phosphorylated
0 
0.5 
1 
1.5 
Ctr9 Paf1 Leo1 Cdc73 Rtf1 R
el
at
iv
e 
P
ro
te
in
 A
bu
nd
an
ce
 (L
ig
ht
/H
ea
vy
 R
at
io
)
A
B
C
D
FIGURE 5. In vivo analysis of PAF-C subunit phosphorylation in Ctr9-FLAG purifications fromWT (heavy) and cka1 cka2–8 (light) strains using
a SILAC approach. A, schematic of the experimental approach. B, relative PAF-C subunit abundance as determined by SILAC. The data are shown as the
light/heavy ratio, with the ratio variance shown as error bars. C, precursor ion abundance for the Leo1 peptide KFYGEDANNFSDQDETT-HTFKEENVELVR
containing unmodified serine 132 (charge,4).D, precursor ion abundance for the Leo1 peptide KFYGEDANNFSPO4DQDETTHTFKEENVELVR containing
phosphorylated serine 132 (charge,3). The ion series for light (cka1 cka2–8) peptides is shown in blue, whereas the heavy ion series (WT) is shown
in red.
CKII Phosphorylates PAF-C
JUNE 24, 2016•VOLUME 291•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 13417
tion by CKII in vitro and in vivo should result in the functional
annotation of PAF-C and CKII as having both a transient pro-
tein-protein interaction and an enzyme-substrate relationship.
Our data show that CKII is a novel upstream regulator of
H2B-K123ub1. We hypothesized that CKII phosphorylation of
PAF-C could be required for FACT and/or PAF-C-dependent
control ofH2B-K123ub1.We have clearly shown that CKII reg-
ulates PAF-C phosphorylation and H2B-K123ub1. However,
our initial genetic studies on PAF-C phosphorylation have not
shown that PAF-C phosphorylation is required for H2B-
K123ub1. There are many possible reasons for this. First, it is
possible that CKII phosphorylation needs to be disrupted on
multiple PAF-C subunits to fully recapitulate the cka1 cka2–8
phenotype. Additionally, it is possible that phosphorylation
sites are present across these subunits that were not detected in
our mass spectrometry analysis because of low peptide detect-
ability and/or overdigestionwith trypsin.Our findings that Paf1
phosphorylation increases at threonine 127 in cka1 cka2–8
strains could suggest that other kinases can compensate for the
loss of CKII activity. Finally, it is also plausible that the regula-
tion of H2B-K123ub1 by CKII occurs in a PAF-C-independent
mechanism.
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